Marburg is one scary disease. The fatality rate can be as high as 88%. There's no approved vaccine — yet. With one of the world's largest outbreaks, Rwanda is now testing a promising new vaccine.

The nonprofit vaccine developer has now sent about 1,700 shots to Rwanda, where Marburg cases have been mostly concentrated among health workers who got the virus while treating sick patients. How ...

Marburg vaccines are set to arrive in Rwanda in the coming days to help protect healthcare workers fighting an outbreak of the deadly haemorrhagic fever. The jabs, developed by the Sabin Vaccine ...

Oxford University, which is developing another Marburg vaccine, had about 1,000 doses. Larger-scale production could be needed, especially if the outbreak becomes more widespread.

Experimental vaccines and therapeutics to combat the deadly Marburg virus will begin arriving this weekend in Rwanda, where they will be used in clinical trials expected to begin soon, a U.S ...

WASHINGTON, April 16, 2025 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute has launched a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate, administering doses to ...

Rwandan health authorities will begin a vaccine study against the Marburg hemorrhagic fever as the East African country tries to stop the spread of an outbreak that has killed 12 people.

KIGALI, Rwanda (AP) — Rwandan health authorities will begin a vaccine study against the Marburg hemorrhagic fever, officials said Sunday, as the East African country tries to stop the spread of ...

Marburg is one scary disease. The fatality rate can be as high as 88%. There's no approved vaccine — yet. With one of the world's largest outbreaks, Rwanda is now testing a promising new vaccine.

WASHINGTON, April 16, 2025 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute has launched a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate, administering doses to ...

The University of Oxford announced recently that researchers initiated the first-in-human trial of a Marburg virus vaccine to test its safety and evaluate its immune response among a young ...